Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan

Alpha Tau Medical Ltd. (NASDAQ:DRTS, DRTSW)) ("Alpha Tau"), the developer of the innovative

- Following the pre-specified interim safety report and overwhelming demand from clinicians to treat

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and

Barclays analyst Lukas Shumway maintains Alpha Tau Medical (NASDAQ:DRTS) with a Overweight and ra

Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELY

- Joint partnership leverages Alpha Tau's highly potent, localized alpha-radiation technology an

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and

- Results reinforce the potential feasibility and safety of Alpha DaRT as a one-time, minimally inva

Barclays analyst Lukas Shumway initiates coverage on Alpha Tau Medical (NASDAQ:DRTS) with a Overw

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and

Piper Sandler analyst Jason Bednar maintains Alpha Tau Medical (NASDAQ:DRTS) with a Neutral and r

Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.26) per share which missed the anal

Ladenburg Thalmann analyst Jeff Cohen maintains Alpha Tau Medical (NASDAQ:DRTS) with a Buy and ra

HC Wainwright & Co. analyst Yi Chen maintains Alpha Tau Medical (NASDAQ:DRTS) with a Buy and

Alpha Tau Medical stock surged after interim glioblastoma data showed complete responses in two pati

By enabling two complementary delivery pathways - endoscopic ultrasound (EUS) and percutaneous - wit

- 100% local disease control rate achieved in evaluable patients in pooled analysis of two first-in-

- Abstract accepted at the American Society of Clinical Oncology (ASCO) Annual Meeting - the world&#

Alpha Tau Medical Ltd. (NASDAQ:DRTS, DRTSW)) ("Alpha Tau"), the developer of the innovative

ACAPELLA is the European multicenter clinical trial evaluating Alpha DaRT alpha-emitter radiotherape

Citigroup analyst Yigal Nochomovitz maintains Alpha Tau Medical (NASDAQ:DRTS) with a Buy and rais

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and

Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.14) per share which missed the anal

Piper Sandler analyst Jason Bednar downgrades Alpha Tau Medical (NASDAQ:DRTS) from Overweight to

HC Wainwright & Co. analyst Yi Chen maintains Alpha Tau Medical (NASDAQ:DRTS) with a Buy and

Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau"), the developer of the innovative

- Initial module submission marks an important milestone in the pre-market approval process - - Flex

Citigroup analyst Yigal Nochomovitz maintains Alpha Tau Medical (NASDAQ:DRTS) with a Buy and lowe

Alpha Tau Medical surged in after-hours trading after treating the first patient in its pilot study

Alpha Tau Medical Ltd. (NASDAQ:DRTS, DRTSW))), the developer of the innovative alpha-radiation cance

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and

Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.14) per share which missed the anal

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and

Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.13) per share which missed the anal

  On Friday, 469 companies hit new 52-week lows.

  During Wednesday's session, 104 stocks hit new 52-week lows.

Gainers BigBear.ai Holdings, Inc. (NYSE: BBAI) shares jumped 239% to $2.8715 after the company an

  Tuesday's session saw 325 companies set new 52-week lows.